Lymphedema
-
Ridner concludes five-year multisite trial to assess lymphedema prevention
Vanderbilt University School of Nursing Professor Sheila Ridner, PhD, FAAN, recently completed a large randomized trial to assess early detection methods coupled with a prevention intervention for a common side effect of breast-cancer treatments—lymphedema. Read MoreMay. 12, 2022
-
Faculty Innovators: Sheila Ridner and Barbara Murphy spearhead trials for first at-home head and neck lymphedema treatment device
Vanderbilt University professors Sheila Ridner at the School of Nursing and Barbara Murphy at the School of Medicine have contributed to the development of a first-of-its-kind device to treat head and neck lymphedema–a chronic disease that causes fluid buildup in the body and can complicate normal functions. When this disease occurs in the head… Read MoreOct. 14, 2021
-
Technology better than tape measure for identifying lymphedema risk
Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema after breast cancer surgery, according to interim results of a study led by Sheila Ridner, PhD, RN, Martha Ingram Professor and director of the PhD in Nursing Science Program at Vanderbilt University School of Nursing. Read MoreMay. 3, 2019
-
VUSN professor receives American Cancer Society grant to study self-care for cancer survivors
Vanderbilt University School of Nursing (VUSN) Assistant Professor Jie Deng, Ph.D., R.N., OCN, FAAN, has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis (LEF). LEF… Read MoreDec. 6, 2016
-
VUSN professor receives American Cancer Society grant to study self-care for cancer survivors
Vanderbilt University School of Nursing (VUSN) Assistant Professor Jie Deng, Ph.D., R.N., OCN, FAAN, has been awarded a $789,000 research scholar grant by the American Cancer Society to develop and test a self-care program for head and neck cancer survivors diagnosed with secondary lymphedema and fibrosis (LEF). LEF… Read MoreDec. 2, 2016